Your browser doesn't support javascript.
loading
Optimising pyrazinamide for the treatment of tuberculosis.
Zhang, Nan; Savic, Radojka M; Boeree, Martin J; Peloquin, Charles A; Weiner, Marc; Heinrich, Norbert; Bliven-Sizemore, Erin; Phillips, Patrick P J; Hoelscher, Michael; Whitworth, William; Morlock, Glenn; Posey, James; Stout, Jason E; Mac Kenzie, William; Aarnoutse, Robert; Dooley, Kelly E.
Afiliación
  • Zhang N; University of California, San Francisco, School of Pharmacy, San Francisco, CA, USA.
  • Savic RM; University of California, San Francisco, School of Pharmacy, San Francisco, CA, USA.
  • Boeree MJ; Depts of Lung Diseases and Pharmacy, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands.
  • Peloquin CA; College of Pharmacy and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.
  • Weiner M; Veterans Administration Medical Center, San Antonio, TX, USA.
  • Heinrich N; Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich, and German Center for Infection Research (DZIF), Munich Partner site, Munich, Germany.
  • Bliven-Sizemore E; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Phillips PPJ; Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
  • Hoelscher M; Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich, and German Center for Infection Research (DZIF), Munich Partner site, Munich, Germany.
  • Whitworth W; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Morlock G; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Posey J; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Stout JE; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
  • Mac Kenzie W; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Aarnoutse R; Depts of Lung Diseases and Pharmacy, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands.
  • Dooley KE; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Eur Respir J ; 58(1)2021 07.
Article en En | MEDLINE | ID: mdl-33542052
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Antibióticos Antituberculosos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Eur Respir J Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Antibióticos Antituberculosos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Eur Respir J Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos